Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07813481
What this trial is testing

ELderly REspiratory VIral Cohort

Who this might be right for
Influenza VirusesRespiratory Syncytial Virus (RSV)Severe Acute Respiratory Syndrome Coronavirus 2+5 more
Assistance Publique - Hôpitaux de Paris 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04370834
What this trial is testing

Tocilizumab for Patients With Cancer and COVID-19 Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT04390165
What this trial is testing

Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study

Who this might be right for
SARS-CoV InfectionCOVID-19Anosmia+1 more
Hospital Sultanah Bahiyah 498
Not applicableStudy completedNCT04371471
What this trial is testing

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

Who this might be right for
SARS-CoV-2 Acute Respiratory DiseaseCovid19
Groupe Hospitalier de la Rochelle Ré Aunis 91
Large-scale testing (Phase 3)Ended earlyNCT04341727
What this trial is testing

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

Who this might be right for
Coronavirus Infection
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT05077267
What this trial is testing

ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Who this might be right for
COVID-19 Disease
Bavarian Nordic 197
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Large-scale testing (Phase 3)Study completedNCT04546581
What this trial is testing

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Who this might be right for
COVIDCOVID-19SARS-CoV-2+1 more
University of Minnesota 593
Not applicableStudy completedNCT04606407
What this trial is testing

Inhaled NO for the Treatment of Viral Pneumonia in Adults

Who this might be right for
Viral PneumoniaNitric OxideRespiratory Disease+4 more
Beyond Air Inc. 40
Not applicableActive Not RecruitingNCT07816471
What this trial is testing

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more
Hospital Italiano de Buenos Aires 350
Not applicableStudy completedNCT04364711
What this trial is testing

EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19

Who this might be right for
COVID-19SARS-CoV 2
UMC Utrecht 300
Large-scale testing (Phase 3)UnknownNCT05445934
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

Who this might be right for
COVID-19
Frontier Biotechnologies Inc. 1,188
Not applicableStudy completedNCT04344977
What this trial is testing

Collection of Anti-SARS-CoV-2 Immune Plasma

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 151
Testing effectiveness (Phase 2)Study completedNCT04375397
What this trial is testing

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury

Who this might be right for
CoronaVirus Induced Disease-2019 (COVID-19)
AbbVie 46
Early research (Phase 1)Study completedNCT05441215
What this trial is testing

Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women

Who this might be right for
Healthy Participants
Pfizer 8
Large-scale testing (Phase 3)UnknownNCT04519125
What this trial is testing

Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19
Hospital Universitario San Ignacio 950
Not applicableStudy completedNCT05977192
What this trial is testing

Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination

Who this might be right for
Vaccination Hesitancy
Oklahoma State University 60
Testing effectiveness (Phase 2)Study completedNCT04558476
What this trial is testing

Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation

Who this might be right for
Covid19Mechanical Ventilation ComplicationCorona Virus Infection+2 more
University of Liege 475
Testing effectiveness (Phase 2)Study completedNCT04625738
What this trial is testing

Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome

Who this might be right for
COVID19 ARDS
Central Hospital, Nancy, France 30
Next Page